Epilepsy occurs in about 90% of these patients43,44, with GRIN2A mutations representing the best known genetic cause of epilepsy-aphasia spectrum (EAS) disorders, where they account for 9–20% of cases42,45–49. Here, GRIN2A is linked to epilepsy.